Journal article
Metabolomic profile of genetic liability to type 2 diabetes among 125,000 Mexican adults: a Mendelian randomisation study
- Abstract:
-
Objective: The Mexican population experiences a notably high prevalence of type 2 diabetes (T2D) and high T2D-associated disease risks. We used targeted plasma NMR-metabolomics data within a Mendelian randomisation framework to characterise the metabolomic profile of genetically-predicted liability to T2D in this population.
Research Design and Methods: Between 1998 and 2004, 50,000 men and 100,000 women ≥35 years were recruited from Mexico City. Mendelian randomisation analyses used a genetic risk score (GRS) comprising 1055 established T2D-associated risk variants and eight pathway-specific T2D GRSs constructed from non-overlapping subsets of these variants to estimate associations with 143 metabolic biomarkers (including lipids, lipoproteins, fatty acids, amino acids, ketone bodies and other low molecular weight biomarkers).
Results: Among 125,587 included participants, the T2D GRS explained 6.0% of T2D liability and was not associated with major potential confounders of the relationships of T2D with the circulating metabolome. Genetically-predicted liability to T2D was strongly positively associated with concentrations of VLDL particles and lipids within these, with triglycerides, branch chain amino acids and glycoprotein acetyls, and more modestly positively associated with IDL and LDL, particularly small LDL, particles. Inverse associations were found with relative concentrations of several fatty acids. Pathway-specific T2D GRSs all associated with higher T2D risk but showed differential relationships with circulating metabolic biomarkers.
Conclusions: T2D is associated with widespread changes in the circulating metabolome among adults in Mexico reflecting diverse biological mechanisms and highlighting the importance of effective T2D management, including control of T2Dassociated dyslipidaemia, in this population.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 117.0KB, Terms of use)
-
(Supplementary materials, zip, 14.3MB, Terms of use)
-
- Publisher copy:
- 10.2337/dc25-2933
Authors
+ Medical Research Council
More from this funder
- Funder identifier:
- https://ror.org/03x94j517
- Grant:
- MC_UU_00017/2
- MR/Z504543/1
- Publisher:
- American Diabetes Association
- Journal:
- Diabetes Care More from this journal
- Publication date:
- 2026-03-27
- Acceptance date:
- 2026-02-06
- DOI:
- EISSN:
-
1935-5548
- ISSN:
-
0149-5992
- Language:
-
English
- Keywords:
- Pubs id:
-
2372284
- Local pid:
-
pubs:2372284
- Deposit date:
-
2026-02-13
- ARK identifier:
Terms of use
- Copyright holder:
- American Diabetes Association.
- Copyright date:
- 2026
- Rights statement:
- © 2026 by the American Diabetes Association.
- Notes:
- The author accepted manuscript (AAM) of this paper has been made available under the University of Oxford's Open Access Publications Policy, and a CC BY public copyright licence has been applied.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record